{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:59:46Z","timestamp":1793779186497,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-026-01725-4","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:04:09Z","timestamp":1782723849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Engineered circular RNA compatible with complete nucleoside modification and rolling circle translation through a Cap-independent translation enhancer"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0845-7228","authenticated-orcid":false,"given":"Xinyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6520-0949","authenticated-orcid":false,"given":"Qian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haomeng","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1673-5124","authenticated-orcid":false,"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligaoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5545-1111","authenticated-orcid":false,"given":"Yong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-2972","authenticated-orcid":false,"given":"Liang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"1725_CR1","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","volume":"53","author":"D Laczk\u00f3","year":"2020","unstructured":"Laczk\u00f3, D. et al. A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice. Immunity 53, 724\u2013732.e7 (2020).","journal-title":"Immunity"},{"key":"1725_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21037-2","volume":"12","author":"Q Huang","year":"2021","unstructured":"Huang, Q. et al. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. Nat. Commun. 12, 776 (2021).","journal-title":"Nat. Commun."},{"key":"1725_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","volume":"182","author":"N-N Zhang","year":"2020","unstructured":"Zhang, N.-N. et al. A thermostable mRNA vaccine against COVID-19. Cell 182, 1271\u20131283.e16 (2020).","journal-title":"Cell"},{"key":"1725_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","volume":"592","author":"AB Vogel","year":"2021","unstructured":"Vogel, A. B. et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature 592, 283\u2013289 (2021).","journal-title":"Nature"},{"key":"1725_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586, 594\u2013599 (2020).","journal-title":"Nature"},{"key":"1725_CR6","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","volume":"383","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N. Engl. J. Med. 383, 1544\u20131555 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1725_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586, 567\u2013571 (2020).","journal-title":"Nature"},{"key":"1725_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1725_CR9","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1002\/dvdy.20995","volume":"235","author":"M Fink","year":"2006","unstructured":"Fink, M., Flekna, G., Ludwig, A., Heimbucher, T. & Czerny, T. Improved translation efficiency of injected mRNA during early embryonic development. Dev. Dyn. 235, 3370\u20133378 (2006).","journal-title":"Dev. Dyn."},{"key":"1725_CR10","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","volume":"185","author":"L Qu","year":"2022","unstructured":"Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185, 1728\u20131744.e16 (2022).","journal-title":"Cell"},{"key":"1725_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).","journal-title":"Nat. Commun."},{"key":"1725_CR12","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/thno.77350","volume":"12","author":"H Li","year":"2022","unstructured":"Li, H. et al. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics 12, 6422\u20136436 (2022).","journal-title":"Theranostics"},{"key":"1725_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302191120","volume":"120","author":"L Amaya","year":"2023","unstructured":"Amaya, L. et al. Circular RNA vaccine induces potent T cell responses. Proc. Natl Acad. Sci. USA 120, e2302191120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1725_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102250","volume":"6","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Synergically enhanced anti-tumor immunity of in vivo panCAR by circRNA vaccine boosting. Cell Rep. Med. 6, 102250 (2025).","journal-title":"Cell Rep. Med."},{"key":"1725_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165\u2013175 (2005).","journal-title":"Immunity"},{"key":"1725_CR16","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840 (2008).","journal-title":"Mol. Ther."},{"key":"1725_CR17","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1016\/j.cell.2025.05.032","volume":"188","author":"M B\u00e9routi","year":"2025","unstructured":"B\u00e9routi, M. et al. Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement. Cell 188, 4880\u20134895.e15 (2025).","journal-title":"Cell"},{"key":"1725_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.ads4539","volume":"388","author":"M Kim","year":"2025","unstructured":"Kim, M. et al. Exogenous RNA surveillance by proton-sensing TRIM25. Science 388, eads4539 (2025).","journal-title":"Science"},{"key":"1725_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.molcel.2019.02.015","volume":"74","author":"RA Wesselhoeft","year":"2019","unstructured":"Wesselhoeft, R. A. et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol. Cell 74, 508\u2013520.e4 (2019).","journal-title":"Mol. Cell"},{"key":"1725_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51044-y","volume":"15","author":"C-I Su","year":"2024","unstructured":"Su, C.-I. et al. A cis-acting ligase ribozyme generates circular RNA in vitro for ectopic protein functioning. Nat. Commun. 15, 6607 (2024).","journal-title":"Nat. Commun."},{"key":"1725_CR21","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41587-024-02393-y","volume":"43","author":"H Chen","year":"2025","unstructured":"Chen, H. et al. Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation. Nat. Biotechnol. 43, 1128\u20131143 (2025).","journal-title":"Nat. Biotechnol."},{"key":"1725_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","volume":"76","author":"YG Chen","year":"2019","unstructured":"Chen, Y. G. N6-methyladenosine modification controls circular RNA immunity. Mol. Cell 76, 96\u2013109.e9 (2019).","journal-title":"Mol. Cell"},{"key":"1725_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.molcel.2021.11.019","volume":"82","author":"C-X Liu","year":"2022","unstructured":"Liu, C.-X. et al. RNA circles with minimized immunogenicity as potent PKR inhibitors. Mol. Cell 82, 420\u2013434.e6 (2022).","journal-title":"Mol. Cell"},{"key":"1725_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molcel.2017.05.022","volume":"67","author":"YG Chen","year":"2017","unstructured":"Chen, Y. G. et al. Sensing self and foreign circular RNAs by intron identity. Mol. Cell 67, 228\u2013238.e5 (2017).","journal-title":"Mol. Cell"},{"key":"1725_CR25","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1002\/anie.201302044","volume":"52","author":"N Abe","year":"2013","unstructured":"Abe, N. et al. Rolling circle amplification in a prokaryotic translation system using small circular RNA. Angew. Chem. Int. Ed. 52, 7004\u20137008 (2013).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1725_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep16435","volume":"5","author":"N Abe","year":"2015","unstructured":"Abe, N. et al. Rolling circle translation of circular RNA in living human cells. Sci. Rep. 5, 16435 (2015).","journal-title":"Sci. Rep."},{"key":"1725_CR27","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1039\/D0CC02140G","volume":"56","author":"K Nakamoto","year":"2020","unstructured":"Nakamoto, K. et al. Chemically synthesized circular RNAs with phosphoramidate linkages enable rolling circle translation. Chem. Commun. 56, 6217\u20136220 (2020).","journal-title":"Chem. Commun."},{"key":"1725_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31327-y","volume":"13","author":"X Fan","year":"2022","unstructured":"Fan, X., Yang, Y., Chen, C. & Wang, Z. Pervasive translation of circular RNAs driven by short IRES-like elements. Nat. Commun. 13, 3751 (2022).","journal-title":"Nat. Commun."},{"key":"1725_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.chembiol.2023.09.015","volume":"31","author":"MJ Unti","year":"2024","unstructured":"Unti, M. J. & Jaffrey, S. R. Highly efficient cellular expression of circular mRNA enables prolonged protein expression. Cell Chem. Biol. 31, 163\u2013176.e5 (2024).","journal-title":"Cell Chem. Biol."},{"key":"1725_CR30","doi-asserted-by":"publisher","first-page":"21197","DOI":"10.1074\/jbc.R110.111476","volume":"285","author":"WC Merrick","year":"2010","unstructured":"Merrick, W. C. Eukaryotic protein synthesis: still a mystery. J. Biol. Chem. 285, 21197\u201321201 (2010).","journal-title":"J. Biol. Chem."},{"key":"1725_CR31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 27, 626\u2013641 (2017).","journal-title":"Cell Res."},{"key":"1725_CR32","doi-asserted-by":"crossref","unstructured":"Miras, M., Miller, W. A., Truniger, V. & Aranda, M. A. Non-canonical Translation in plant RNA viruses. Front. Plant Sci. 8, 494 (2017).","DOI":"10.3389\/fpls.2017.00494"},{"key":"1725_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-micro-092412-155609","volume":"67","author":"AE Simon","year":"2013","unstructured":"Simon, A. E. & Miller, W. A. 3\u2032 cap-independent translation enhancers of plant viruses. Annu. Rev. Microbiol. 67, 21\u201342 (2013).","journal-title":"Annu. Rev. Microbiol."},{"key":"1725_CR34","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrg2438","volume":"9","author":"WF Marzluff","year":"2008","unstructured":"Marzluff, W. F., Wagner, E. J. & Duronio, R. J. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet. 9, 843\u2013854 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"1725_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41587-019-0090-6","volume":"37","author":"JL Litke","year":"2019","unstructured":"Litke, J. L. & Jaffrey, S. R. Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. Nat. Biotechnol. 37, 667\u2013675 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1725_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02460-2","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector. Sci. Rep. 7, 2193 (2017).","journal-title":"Sci. Rep."},{"key":"1725_CR37","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1093\/nar\/gkr074","volume":"39","author":"A Orioli","year":"2011","unstructured":"Orioli, A. et al. Widespread occurrence of non-canonical transcription termination by human RNA polymerase III. Nucleic Acids Res. 39, 5499\u20135512 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1725_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.omtn.2023.07.034","volume":"33","author":"KH Lee","year":"2023","unstructured":"Lee, K. H. et al. Efficient circular RNA engineering by end-to-end self-targeting and splicing reaction using Tetrahymena group I intron ribozyme. Mol. Ther. Nucleic Acids 33, 587\u2013598 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1725_CR39","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","volume":"177","author":"C-X Liu","year":"2019","unstructured":"Liu, C.-X. et al. Structure and degradation of circular RNAs regulate PKR activation in innate immunity. Cell 177, 865\u2013880.e21 (2019).","journal-title":"Cell"},{"key":"1725_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41551-025-01344-5","volume":"9","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Small circular RNAs as vaccines for cancer immunotherapy. Nat. Biomed. Eng. 9, 249\u2013267 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"1725_CR41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.vaccine.2023.12.052","volume":"42","author":"A Kachko","year":"2024","unstructured":"Kachko, A. et al. Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models. Vaccine 42, 608\u2013619 (2024).","journal-title":"Vaccine"},{"key":"1725_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","volume":"26","author":"E O\u2019Leary","year":"2025","unstructured":"O\u2019Leary, E., Jiang, Y., Kristensen, L. S., Hansen, T. B. & Kjems, J. The therapeutic potential of circular RNAs. Nat. Rev. Genet. 26, 230\u2013244 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"1725_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng, Z. et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Sig. Transduct. Target. Ther. 9, 234 (2024).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"1725_CR44","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","volume":"58","author":"J Lau","year":"2015","unstructured":"Lau, J. et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J. Med. Chem. 58, 7370\u20137380 (2015).","journal-title":"J. Med. Chem."},{"key":"1725_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08793-y","volume":"10","author":"J Fremaux","year":"2019","unstructured":"Fremaux, J. et al. Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo. Nat. Commun. 10, 924 (2019).","journal-title":"Nat. Commun."},{"key":"1725_CR46","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"M-G Alameh","year":"2021","unstructured":"Alameh, M.-G. et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity 54, 2877\u20132892.e7 (2021).","journal-title":"Immunity"},{"key":"1725_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41551-023-01082-6","volume":"9","author":"B Li","year":"2023","unstructured":"Li, B. et al. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA. Nat. Biomed. Eng. 9, 167\u2013184 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"1725_CR48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell, J. et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes. Metab. 19, 1242\u20131251 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"1725_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","volume":"371","author":"C Krienke","year":"2021","unstructured":"Krienke, C. et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 371, 145\u2013153 (2021).","journal-title":"Science"},{"key":"1725_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412543","volume":"12","author":"F Wang","year":"2025","unstructured":"Wang, F. et al. A spleen-targeted tolerogenic mRNA-LNPs vaccine for the treatment of experimental asthma. Adv. Sci. 12, 2412543 (2025).","journal-title":"Adv. Sci."},{"key":"1725_CR51","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.immuni.2021.02.003","volume":"54","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Cytoplasmic DNA sensing by KU complex in aged CD4+ T cell potentiates T cell activation and aging-related autoimmune inflammation. Immunity 54, 632\u2013647.e9 (2021).","journal-title":"Immunity"},{"key":"1725_CR52","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806\u20132827 (2022).","journal-title":"Cell"},{"key":"1725_CR53","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.cell.2023.04.024","volume":"186","author":"MAG Hoffmann","year":"2023","unstructured":"Hoffmann, M. A. G. et al. ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines. Cell 186, 2380\u20132391.e9 (2023).","journal-title":"Cell"},{"key":"1725_CR54","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","volume":"39","author":"D Yin","year":"2021","unstructured":"Yin, D. et al. Targeting herpes simplex virus with CRISPR\u2013Cas9 cures herpetic stromal keratitis in mice. Nat. Biotechnol. 39, 567\u2013577 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1725_CR55","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41573-025-01237-x","volume":"24","author":"S Wang","year":"2025","unstructured":"Wang, S., Weissman, D. & Dong, Y. RNA chemistry and therapeutics. Nat. Rev. Drug Discov. 24, 828\u2013851 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1725_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz6893","volume":"6","author":"J Nelson","year":"2020","unstructured":"Nelson, J. et al. Impact of mRNA chemistry and manufacturing process on innate immune activation. Sci. Adv. 6, eaaz6893 (2020).","journal-title":"Sci. Adv."},{"key":"1725_CR57","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41551-024-01306-3","volume":"9","author":"Y Du","year":"2024","unstructured":"Du, Y. et al. Efficient circular RNA synthesis for potent rolling circle translation. Nat. Biomed. Eng. 9, 1062\u20131074 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"1725_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/science.adr6006","volume":"387","author":"K Jiang","year":"2025","unstructured":"Jiang, K. et al. Rapid in silico directed evolution by a protein language model with EVOLVEpro. Science 387, eadr6006 (2025).","journal-title":"Science"},{"key":"1725_CR59","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41587-022-01525-6","volume":"41","author":"A Dousis","year":"2023","unstructured":"Dousis, A., Ravichandran, K., Hobert, E. M., Moore, M. J. & Rabideau, A. E. An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts. Nat. Biotechnol. 41, 560\u2013568 (2023).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01725-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:04:19Z","timestamp":1782723859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01725-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":59,"alternative-id":["1725"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01725-4","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.Q., Q.P., X.W., J.Y. and H.K. have patent applications (202610314322.6, China, 2026; 202411321224.2, China, 2024) related to this study. L.Q. is the founder of JianJie BioTech. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}